Neural differentiation and prognosis in peripheral primitive neuroectodermal tumor.

[1]  S. Ferrari,et al.  Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  S. Steinberg,et al.  Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. , 1999, Human pathology.

[3]  P. Sorensen,et al.  EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Ambros,et al.  Prognostic impact of deletions at 1p36 and numerical aberrations in Ewing tumors , 1999, Genes, chromosomes & cancer.

[5]  W. Gerald,et al.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  S. Ferrari,et al.  Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.